Updated:
Charlotte's Web Holdings
Charlotte's Web Holdings, the hemp-derived CBD company founded by the Stanley brothers in Colorado, supplies national retailers from FDA-registered...
Charlotte's Web Holdings
Charlotte's Web Holdings was founded in 2013 by seven Stanley brothers in Colorado, emerging from a nonprofit they had formed to breed a low-THC, high-CBD hemp strain for a young epilepsy patient named Charlotte Figi. The cultivar, later named after Charlotte, became the foundation of one of the most recognized CBD brands in the United States. The firm went public on the Canadian Securities Exchange in 2018 and now trades on the TSX. Charlotte's Web operates as a vertically integrated hemp-derived CBD company, handling cultivation, extraction, manufacturing, and distribution in-house. The product portfolio spans tinctures, capsules, gummies, topicals, and pet formulations distributed through more than 15,000 retail locations including Kroger, CVS, and Sprouts Farmers Market, as well as direct-to-consumer ecommerce. The company does not participate in the legal marijuana market; its products are derived from federally legal industrial hemp, explicitly avoiding the regulatory constraints of state-licensed cannabis dispensaries. Bill Morachnick was appointed CEO in early 2025, taking over from Jacques Tortoroli, with a mandate to stabilize operations after several years of revenue decline and a 2023 NASDAQ delisting that moved the stock to the TSX. The company operates its primary production campus in Louisville, Colorado, and maintains an FDA-registered facility. Charlotte's Web has made no material acquisitions since 2021 and has not formed adjacent venture arms or real-estate vehicles. Charlotte's Web is structurally distinct from most publicly traded cannabis operators in its medical-origin DNA and its strict adherence to the hemp-only federal exemption. While competitors like Tilray and Curaleaf pursue vertically integrated marijuana operations across multiple state and international markets, Charlotte's Web remains narrowly focused on the consumer packaged goods channel for CBD. This has limited scale but insulated the company from the capital-intensity and complex licensing burdens of plant-touching marijuana operators.
General information
Firm type
Asset Manager
Year founded
2013
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Louisville
Corporate office
Louisville, CO, United States
Principals
Bill Morachnick
Chief Executive Officer
Jesse Stanley
Co-Founder
Joel Stanley
Co-Founder
Sector focus
Frequently asked questions
What is the origin of the name Charlotte's Web?
The company is named after Charlotte Figi, a young girl with Dravet syndrome whose seizures were dramatically reduced using a low-THC, high-CBD hemp extract bred by the Stanley brothers in Colorado. Her story was featured in a 2013 CNN documentary by Dr. Sanjay Gupta, which brought national attention to the therapeutic potential of CBD. Charlotte passed away in 2020, but the brand remains closely associated with the medical cannabis movement.
Does Charlotte's Web sell marijuana products or only hemp-derived CBD?
Charlotte's Web exclusively sells hemp-derived CBD products containing less than 0.3% THC, in compliance with the 2018 Farm Bill. The company does not operate in state-licensed marijuana markets and does not sell any products that would require a dispensary license. This positions Charlotte's Web in the consumer packaged goods channel rather than the regulated cannabis dispensary channel.
Who runs investment decisions at Charlotte's Web?
As a publicly traded operating company rather than an investment firm, capital allocation decisions are made by the CEO and board of directors, not an investment committee. Bill Morachnick, appointed CEO in February 2025, leads strategic and operational decisions. The firm has not disclosed a chief investment officer or dedicated investment team, consistent with its structure as a vertically integrated consumer products manufacturer.
Why was Charlotte's Web delisted from the NASDAQ?
Charlotte's Web was delisted from the NASDAQ in October 2023 after its share price failed to meet the exchange's minimum bid requirement. The company's stock moved to the Toronto Stock Exchange, its original listing venue prior to the 2021 NASDAQ uplisting. The delisting did not constitute a bankruptcy or restructuring event, and the firm continues to file as a public reporting issuer in both Canada and the United States.
What is Charlotte's Web's relationship with the Stanley brothers?
The company was founded by seven Stanley brothers — Jesse, Joel, Jon, Jordan, Jared, Josh, and Austin Stanley — who originally operated as a nonprofit before incorporating in 2013. Joel Stanley served as CEO until 2021. The brothers' ongoing involvement has diminished over time, with professional management presiding over the company since 2021. None of the Stanley brothers hold executive roles as of 2025.
Does Charlotte's Web operate internationally?
Charlotte's Web does not have material international operations. The company's revenue is generated almost entirely within the United States through retail distribution and direct-to-consumer ecommerce. The company has not disclosed any production facilities, subsidiaries, or distribution agreements outside the U.S., and its regulatory posture under the 2018 Farm Bill is specific to the domestic hemp market.
Has Charlotte's Web made acquisitions or formed venture arms?
Charlotte's Web acquired Abacus Health Products in 2021 in a transaction that expanded its topical product line, but has not completed any acquisitions since that date. The company has not formed a corporate venture arm, and none of its public filings indicate an intention to pursue acquisitions as a growth strategy. The firm operates a single legal entity structure without investment subsidiaries.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: